For patients with hepatitis B virus, alcohol is associated with dose-dependent increased risks for cirrhosis and ...
A newly updated clinical practice guideline offers healthcare practitioners vital evidence-based recommendations for managing hepatitis B reactivation (HBVr) in individuals at risk.
HB-500 is a next-generation therapeutic vaccine being developed in collaboration with Gilead Sciences, Inc. (Gilead) as a potential component of ...
Inhibition of HBV replication by delivering the dual-gene expression vector pHsa-miR16-siRNA in HepG2.2.15 cells.